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Burden of Periprosthetic Joint Infection and its Treatment on
Kidney Function
Pouya Alijanipour MD, Snir Heller MD, Camilo Restrepo MD, Collin Ackerman BS, Edward J. Filippone MD, William J. Hozack MD.
Investigation performed at the Rothman Institute at Thomas Jefferson University, Philadelphia, PA.

INTRODUCTION

MATERIALS AND METHODS

Based on the mean of the three highest creatinine values, the incidence of kidney
injury in PJI and aseptic groups was 26% (72/282) and 7% (98/2903), respectively
(p<0.001). The distribution of RIFLE criteria is demonstrated in the table 1. Based on the
final post-treatment Cr values, the incidence of clinically important minimum rise in Cr
level was significantly higher in PJI group (65/282, 23%) compared to aseptic group
(153/2903, 5%; p <0.001). There was weak trend for the influence of number of surgeries
on the incidence of post-treatment residual kidney injury (Spearman’s rho= 0.13,
p=0.03). In multivariate analysis, accumulative intravenous vancomycin dosage (p<0.01),
intraoperative volume repletion (p=0.049), and estimated blood loss (p=0.08) were associated with RIFLE classification (Figures 1-3). The demographic factors, Charlson comorbidity index, use of spacer, duration of surgery, perioperative anemia, transfusion, anticoagulation method and implant type (cemented versus non-cemented) did not have any
association.
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Serum Cr > × 1.5 baseline Cr
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Complete loss of function > 4 weeks

End-stage kidney disease > 3 months
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Table 1.
Distribution of kidney injury as defined by the RIFLE criteria in PJI and aseptic groups.
PJI=Periprosthetic joint infection; Cr=Creatinine.
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We retrospectively collected data on 3185 consecutive patients who underwent revision arthroplasty due to PJI (282) or aseptic (2903) failure during 2000-2011. Baseline and
postoperative serum creatinine (Cr) levels were used to define kidney injury, based on
the RIFLE (Risk, Injury, Failure, Loss and End-stage kidney disease) criteria and clinically
important minimum rise in serum Cr level (>0.3 mg/dl)1. Patients with preexisting renal
disease (baseline Cr level >1.2 mg/dl) were excluded. PJI was defined using criteria recently proposed by International Consensus Group on PJI2.
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Patients with periprosthetic joint infection (PJI) are subjected to several potentially
nephrotoxic conditions such as acute and chronic systemic inflammatory reactions, multiple surgical procedures and noxious antibiotics. This study aims to investigate 1) the incidence and severity of kidney injury in patients undergoing surgical treatment for PJI, 2)
whether the number of surgeries affects renal function in PJI patients and 3) the potential
risk factors for kidney injury.

FIGURES 1, 2 & 3

The risk of sustaining clinically significant kidney injury in patients with PJI who undergo revision surgery is increased compared with patients undergoing aseptic revision
arthroplasty. This difference does not seem to be fully explained by the increased
number of surgical procedures in PJI patients. Increased need for intraoperative volume
repletion due to blood loss and intravenous vancomycin administration are significant
risk factors for acute kidney injury following septic revision surgery. Recognition of potential risk factors for such adverse effect should lead to implementation of appropriate
nephron-protective strategies, such as adequate intraoperative hydration and meticulous adjustment of postoperative vancomycin dosage, in PJI patients.
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